Ligand Pharmaceuticals Incorporated LGND NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score

77/100

5/7 Pass

SharesGrow Intrinsic Value

Ligand Pharmaceuticals Incorporated (LGND) 的分析师一致评级为 Buy, 基于 17 位分析师覆盖该股票. 其中, 12 建议买入, 4 建议持有, and 1 建议卖出.

分析师对 LGND is $248.00, 代表 +10.2% 上涨空间较当前价格 $225.09. 目标价格区间从最低 $230.00 到最高 $275.00.

分析师共识 — LGND

Buy

强力买入

买入

持有

卖出

强力卖出

17 位分析师

价格目标

共识$248.00

最高$275.00

最低$230.00

中位数$239.00

上月均价-

上季均价$239.00

去年均价$230.13

历史总数15

其他人也在看

Blueprint Medicines Corporation

$129.46

+0.14%

CYTK

Cytokinetics, Incorporated

$65.37

-1.48%

APLS

Apellis Pharmaceuticals, Inc.

$40.85

-0.01%

TERN

Terns Pharmaceuticals, Inc.

$52.71

+0.06%

AKRO

Akero Therapeutics, Inc.

$54.65

+0.00%

CRNX

Crinetics Pharmaceuticals, Inc.

$39.77

+0.05%

Ligand Pharmaceuticals Incorporated LGND NASDAQ

分析师共识 — LGND

其他人也在看

获取低估股票提醒